Addus HomeCare (NASDAQ:ADUS) Given New $140.00 Price Target at TD Cowen

Addus HomeCare (NASDAQ:ADUS) had its price target lifted by investment analysts at TD Cowen from $139.00 to $140.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. TD Cowen’s price objective would indicate a potential upside of 18.90% from the company’s previous close.

ADUS has been the topic of several other research reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, October 8th. Stephens reiterated an “overweight” rating and issued a $140.00 target price on shares of Addus HomeCare in a report on Wednesday, September 3rd. Barclays raised their price target on shares of Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research report on Tuesday. Cowen restated a “buy” rating on shares of Addus HomeCare in a research report on Wednesday. Finally, JMP Securities restated a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research report on Wednesday, July 16th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and an average target price of $138.63.

Addus HomeCare Stock Up 4.9%

Shares of ADUS traded up $5.53 during mid-day trading on Wednesday, hitting $117.75. 125,106 shares of the company’s stock were exchanged, compared to its average volume of 181,540. The firm has a fifty day moving average of $115.28 and a two-hundred day moving average of $112.41. Addus HomeCare has a twelve month low of $88.96 and a twelve month high of $136.72. The stock has a market cap of $2.17 billion, a price-to-earnings ratio of 25.99, a P/E/G ratio of 1.87 and a beta of 0.86. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 3rd. The company reported $1.56 EPS for the quarter, topping the consensus estimate of $1.53 by $0.03. The company had revenue of $362.30 million for the quarter, compared to analyst estimates of $354.48 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. Addus HomeCare’s quarterly revenue was up 25.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.30 EPS. On average, sell-side analysts forecast that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, Director Veronica Hill-Milbourne sold 1,571 shares of the business’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total value of $180,555.03. Following the completion of the transaction, the director directly owned 5,067 shares of the company’s stock, valued at approximately $582,350.31. The trade was a 23.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the completion of the transaction, the chief executive officer directly owned 166,461 shares of the company’s stock, valued at approximately $19,134,691.95. This represents a 13.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 34,310 shares of company stock valued at $3,958,375 in the last ninety days. Insiders own 4.50% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors have recently modified their holdings of the stock. Ameritas Investment Partners Inc. raised its stake in shares of Addus HomeCare by 5.0% in the second quarter. Ameritas Investment Partners Inc. now owns 1,854 shares of the company’s stock worth $214,000 after acquiring an additional 89 shares during the last quarter. Amalgamated Bank raised its stake in shares of Addus HomeCare by 1.8% in the third quarter. Amalgamated Bank now owns 5,240 shares of the company’s stock worth $618,000 after acquiring an additional 93 shares during the last quarter. First Hawaiian Bank raised its stake in shares of Addus HomeCare by 2.0% in the first quarter. First Hawaiian Bank now owns 4,898 shares of the company’s stock worth $484,000 after acquiring an additional 95 shares during the last quarter. Maryland State Retirement & Pension System raised its stake in shares of Addus HomeCare by 1.9% in the second quarter. Maryland State Retirement & Pension System now owns 5,335 shares of the company’s stock worth $615,000 after acquiring an additional 101 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of Addus HomeCare by 6.3% in the third quarter. GAMMA Investing LLC now owns 1,778 shares of the company’s stock worth $210,000 after acquiring an additional 105 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.